234 related articles for article (PubMed ID: 8772586)
1. Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure.
Hoffman DM; Crampton L; Sernia C; Nguyen TV; Ho KK
J Clin Endocrinol Metab; 1996 Mar; 81(3):1123-8. PubMed ID: 8772586
[TBL] [Abstract][Full Text] [Related]
2. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man.
Møller J; Jørgensen JO; Møller N; Hansen KW; Pedersen EB; Christiansen JS
J Clin Endocrinol Metab; 1991 Apr; 72(4):768-72. PubMed ID: 1826008
[TBL] [Abstract][Full Text] [Related]
3. GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis.
Johannsson G; Sverrisdóttir YB; Ellegård L; Lundberg PA; Herlitz H
J Clin Endocrinol Metab; 2002 Apr; 87(4):1743-9. PubMed ID: 11932310
[TBL] [Abstract][Full Text] [Related]
4. Body fluids, circadian blood pressure and plasma renin during growth hormone administration: a placebo-controlled study with two growth hormone doses in healthy adults.
Moller J; Jorgensen JO; Frandsen E; Laursen T; Christiansen JS
Scand J Clin Lab Invest; 1995 Dec; 55(8):663-9. PubMed ID: 8903836
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone.
Barton JS; Hindmarsh PC; Preece MA; Brook CG
Clin Endocrinol (Oxf); 1993 Mar; 38(3):245-51. PubMed ID: 8458096
[TBL] [Abstract][Full Text] [Related]
6. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
7. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men.
Johannsson G; Gibney J; Wolthers T; Leung KC; Ho KK
J Clin Endocrinol Metab; 2005 Jul; 90(7):3989-94. PubMed ID: 15827107
[TBL] [Abstract][Full Text] [Related]
8. Individualized growth hormone substitution with normalized IGF-I levels does not stimulate the renin-angiotensin-aldosterone system.
Ekman B; Ohman PK; Arnqvist HJ; Lindström T; Nyström FH
Clin Endocrinol (Oxf); 2002 Oct; 57(4):473-9. PubMed ID: 12354129
[TBL] [Abstract][Full Text] [Related]
9. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
10. The effects of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study.
Valk NK; vd Lely AJ; de Herder WW; Lindemans J; Lamberts SW
J Clin Endocrinol Metab; 1994 Oct; 79(4):1070-6. PubMed ID: 7525625
[TBL] [Abstract][Full Text] [Related]
11. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
[TBL] [Abstract][Full Text] [Related]
12. Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.
Berggren A; Ehrnborg C; Rosén T; Ellegård L; Bengtsson BA; Caidahl K
J Clin Endocrinol Metab; 2005 Jun; 90(6):3268-73. PubMed ID: 15784718
[TBL] [Abstract][Full Text] [Related]
13. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis.
de Boer H; Blok GJ; Voerman B; de Vries P; Popp-Snijders C; van der Veen E
J Clin Endocrinol Metab; 1995 Jul; 80(7):2069-76. PubMed ID: 7608257
[TBL] [Abstract][Full Text] [Related]
14. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: a four months double blind placebo controlled trial.
Møller J; Fisker S; Rosenfalck AM; Frandsen E; Jørgensen JO; Hilsted J; Christiansen JS
Eur J Endocrinol; 1999 Jan; 140(1):11-6. PubMed ID: 10037245
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study.
Møller J; Frandsen E; Fisker S; Jørgensen JO; Christiansen JS
Clin Endocrinol (Oxf); 1996 May; 44(5):533-9. PubMed ID: 8762729
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.
de Boer H; Blok GJ; Popp-Snijders C; Stuurman L; Baxter RC; van der Veen E
J Clin Endocrinol Metab; 1996 Apr; 81(4):1371-7. PubMed ID: 8636336
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.
Chapman IM; Bach MA; Van Cauter E; Farmer M; Krupa D; Taylor AM; Schilling LM; Cole KY; Skiles EH; Pezzoli SS; Hartman ML; Veldhuis JD; Gormley GJ; Thorner MO
J Clin Endocrinol Metab; 1996 Dec; 81(12):4249-57. PubMed ID: 8954023
[TBL] [Abstract][Full Text] [Related]
20. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
